← Eichor
Study identifier: NCT07064434 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Sacral Canal Block for Hip Replacement the Efficacy and Safety of Controlled Intraoperative Hypotension

Condition: Postoperative Pain  ·  Sponsor: General Hospital of Ningxia Medical University

PhaseNA
Planned participants80
Who can joinAll sexes, 45 Years to no upper limit
Healthy volunteersYes

About this study

To observe the efficacy and safety of sacral canal block in controlled blood pressure reduction during hip replacement in the elderly, and to provide a better option for controlled blood pressure reduction during clinical hip surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Xinli Ni, MD  ·  13909586966  ·  xinlini6@nyfy.com.cn

Wenxuan Ma  ·  18295009975  ·  769462442@qq.com

Always discuss trial participation with your own doctor first.

Locations (1)

General hospital of Ningxia medical universityYinchuan, Ningxia, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07064434